Royal Bank of Canada Lowers Addus HomeCare (NASDAQ:ADUS) Price Target to $110.00

Addus HomeCare (NASDAQ:ADUSGet Rating) had its price objective cut by Royal Bank of Canada from $111.00 to $110.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock.

A number of other research analysts have also issued reports on ADUS. Bank of America began coverage on Addus HomeCare in a report on Wednesday, April 13th. They issued a buy rating and a $110.00 target price on the stock. Stephens decreased their target price on Addus HomeCare from $110.00 to $101.00 and set an overweight rating on the stock in a research report on Tuesday, June 21st. Finally, Stifel Nicolaus started coverage on Addus HomeCare in a research report on Tuesday, June 28th. They issued a buy rating and a $101.00 price objective on the stock. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Addus HomeCare presently has an average rating of Buy and a consensus target price of $110.40.

Addus HomeCare Trading Up 0.7 %

NASDAQ:ADUS opened at $93.36 on Wednesday. The firm has a market cap of $1.50 billion, a P/E ratio of 33.83, a PEG ratio of 2.46 and a beta of 0.85. The company has a current ratio of 2.00, a quick ratio of 2.65 and a debt-to-equity ratio of 0.33. The stock’s 50 day simple moving average is $86.16 and its 200-day simple moving average is $83.27. Addus HomeCare has a 12-month low of $68.57 and a 12-month high of $108.11.

Addus HomeCare (NASDAQ:ADUSGet Rating) last released its earnings results on Monday, August 1st. The company reported $0.91 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.01). The company had revenue of $236.94 million during the quarter, compared to analyst estimates of $238.40 million. Addus HomeCare had a net margin of 4.90% and a return on equity of 8.63%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.78 EPS. Equities analysts anticipate that Addus HomeCare will post 3.18 EPS for the current year.

Insider Buying and Selling

In related news, EVP David W. Tucker sold 2,080 shares of the firm’s stock in a transaction that occurred on Friday, July 15th. The stock was sold at an average price of $90.00, for a total value of $187,200.00. Following the sale, the executive vice president now directly owns 8,468 shares in the company, valued at approximately $762,120. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, EVP David W. Tucker sold 2,080 shares of Addus HomeCare stock in a transaction on Friday, July 15th. The stock was sold at an average price of $90.00, for a total transaction of $187,200.00. Following the transaction, the executive vice president now directly owns 8,468 shares in the company, valued at approximately $762,120. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael D. Wattenbarger sold 1,718 shares of the firm’s stock in a transaction on Tuesday, May 24th. The stock was sold at an average price of $85.00, for a total value of $146,030.00. Following the sale, the executive vice president now directly owns 7,012 shares of the company’s stock, valued at $596,020. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,940 shares of company stock valued at $344,102. Insiders own 4.50% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently bought and sold shares of the company. Silvercrest Asset Management Group LLC increased its stake in shares of Addus HomeCare by 570.1% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 770,538 shares of the company’s stock worth $71,648,000 after purchasing an additional 655,548 shares during the period. Eaton Vance Management increased its stake in Addus HomeCare by 20.9% during the first quarter. Eaton Vance Management now owns 754,080 shares of the company’s stock valued at $70,348,000 after acquiring an additional 130,469 shares during the period. Ziegler Capital Management LLC bought a new position in Addus HomeCare during the second quarter valued at about $7,539,000. Allspring Global Investments Holdings LLC acquired a new stake in Addus HomeCare during the fourth quarter valued at approximately $6,765,000. Finally, Tributary Capital Management LLC acquired a new stake in Addus HomeCare during the second quarter valued at approximately $4,754,000. Institutional investors and hedge funds own 96.04% of the company’s stock.

About Addus HomeCare

(Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.